query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly2.cif.gz_C Human GPT (DPAGT1) H129 variant in complex with tunicamycin	0.184	355	262	19	340	5	359	1.259E-11	507
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly1.cif.gz_A Human GPT (DPAGT1) H129 variant in complex with tunicamycin	0.181	359	263	19	340	5	363	9.298E-12	505
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly1.cif.gz_B Human GPT (DPAGT1) H129 variant in complex with tunicamycin	0.181	361	263	19	340	5	365	9.298E-12	501
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly2.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly2.cif.gz_D Human GPT (DPAGT1) in complex with tunicamycin	0.180	353	263	19	340	4	356	2.996E-11	489
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly1.cif.gz_B Human GPT (DPAGT1) in complex with tunicamycin	0.176	360	265	19	340	4	363	2.118E-11	485
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw5-assembly2.cif.gz_C Human GPT (DPAGT1) in complex with tunicamycin	0.173	364	265	19	340	5	368	2.212E-11	460
LOKIASV2_2730_ESMFold_hypothetical_protein	5o5e-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	5o5e-assembly1.cif.gz_A-2 Crystal structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) (V264G mutant) in complex with tunicamycin	0.194	370	260	19	341	5	374	1.564E-11	459
LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly2.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6bw6-assembly2.cif.gz_D Human GPT (DPAGT1) H129 variant in complex with tunicamycin	0.172	358	266	19	340	5	362	6.826E-11	451
LOKIASV2_2730_ESMFold_hypothetical_protein	6fwz-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	6fwz-assembly1.cif.gz_A-2 Crystal structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1) (V264G mutant) in complex with UDP-GlcNAc	0.180	362	263	19	340	6	367	3.721E-11	444
LOKIASV2_2730_ESMFold_hypothetical_protein	6fm9-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	6fm9-assembly1.cif.gz_A-2 Crystal structure of human UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase (DPAGT1)	0.181	362	263	19	340	6	367	1.148E-10	432
LOKIASV2_2730_ESMFold_hypothetical_protein	5ckr-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	5ckr-assembly1.cif.gz_A-2 Crystal Structure of MraY in complex with Muraymycin D2	0.167	325	267	16	340	2	322	1.041E-08	376
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly4.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly4.cif.gz_D Crystal structure of MraY bound to carbacaprazamycin	0.176	326	268	15	340	6	331	8.751E-09	372
LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly1.cif.gz_A Crystal structure of MraY bound to a sphaerimicin analogue	0.183	321	249	20	340	4	309	2.820E-08	366
LOKIASV2_2730_ESMFold_hypothetical_protein	5jnq-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	5jnq-assembly1.cif.gz_A-2 MraY tunicamycin complex	0.221	334	232	7	340	4	302	1.350E-08	352
LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly1.cif.gz_A Crystal structure of MraY bound to 3'-hydroxymureidomycin A	0.162	326	267	15	340	6	325	3.211E-08	352
LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly2.cif.gz_B Crystal structure of MraY bound to 3'-hydroxymureidomycin A	0.180	340	258	1	340	1	316	5.173E-08	347
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly1.cif.gz_A Crystal structure of MraY bound to carbacaprazamycin	0.186	325	254	16	340	8	320	3.657E-08	347
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly3.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly3.cif.gz_B Crystal structure of MraY bound to carbacaprazamycin	0.178	336	263	5	340	4	324	3.502E-08	346
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly3.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly3.cif.gz_B Crystal structure of MraY bound to capuramycin	0.182	337	257	4	340	10	324	2.082E-08	346
LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly4.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly4.cif.gz_D Crystal structure of MraY bound to a sphaerimicin analogue	0.176	322	241	19	340	2	294	1.285E-07	345
LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	8cxr-assembly2.cif.gz_C Crystal structure of MraY bound to a sphaerimicin analogue	0.188	321	245	20	340	12	314	7.316E-08	343
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly1.cif.gz_A Crystal structure of MraY bound to capuramycin	0.184	321	246	20	340	5	307	7.316E-08	339
LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly3.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly3.cif.gz_C Crystal structure of MraY bound to 3'-hydroxymureidomycin A	0.180	326	251	15	340	10	316	9.489E-08	329
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly2.cif.gz_C Crystal structure of MraY bound to capuramycin	0.177	331	244	10	340	4	300	1.982E-07	315
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyh-assembly2.cif.gz_C Crystal structure of MraY bound to carbacaprazamycin	0.189	321	251	20	340	12	322	3.965E-07	313
LOKIASV2_2730_ESMFold_hypothetical_protein	8g01-assembly1.cif.gz_E	LOKIASV2_2730_ESMFold_hypothetical_protein	8g01-assembly1.cif.gz_E YES Complex - E. coli MraY, Protein E ID21, E. coli SlyD	0.176	338	276	6	341	17	354	2.462E-07	304
LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly4.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6oyz-assembly4.cif.gz_D Crystal structure of MraY bound to capuramycin	0.171	324	245	18	341	3	299	6.670E-07	301
LOKIASV2_2730_ESMFold_hypothetical_protein	4j72-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	4j72-assembly1.cif.gz_A Crystal Structure of polyprenyl-phosphate N-acetyl hexosamine 1-phosphate transferase	0.181	272	220	6	277	4	273	6.081E-06	246
LOKIASV2_2730_ESMFold_hypothetical_protein	4j72-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	4j72-assembly1.cif.gz_B Crystal Structure of polyprenyl-phosphate N-acetyl hexosamine 1-phosphate transferase	0.173	266	215	24	284	12	277	6.351E-06	238
LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly4.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6oz6-assembly4.cif.gz_D Crystal structure of MraY bound to 3'-hydroxymureidomycin A	0.170	258	204	20	277	2	248	4.662E-05	218
LOKIASV2_2730_ESMFold_hypothetical_protein	7p61-assembly1.cif.gz_N	LOKIASV2_2730_ESMFold_hypothetical_protein	7p61-assembly1.cif.gz_N Complex I from E. coli, DDM-purified, with NADH, Resting state	0.115	456	364	13	424	2	457	1.414E-01	37
LOKIASV2_2730_ESMFold_hypothetical_protein	7b93-assembly1.cif.gz_L	LOKIASV2_2730_ESMFold_hypothetical_protein	7b93-assembly1.cif.gz_L Cryo-EM structure of mitochondrial complex I from Mus musculus inhibited by IACS-2858 at 3.0 A	0.099	415	345	65	448	143	557	5.658E-01	31
LOKIASV2_2730_ESMFold_hypothetical_protein	5lyq-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5lyq-assembly1.cif.gz_A Crystal structure of the Retinoic Acid Receptor alpha in complex with a synthetic spiroketal agonist and a fragment of the TIF2 co-activator.	0.129	237	181	179	415	1	209	5.418E-01	30
LOKIASV2_2730_ESMFold_hypothetical_protein	7pdq-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	7pdq-assembly1.cif.gz_A-2 Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with LG100268 and a coactivator fragment	0.119	230	173	179	408	1	197	8.727E-01	29
LOKIASV2_2730_ESMFold_hypothetical_protein	6sti-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6sti-assembly1.cif.gz_A Crystal structure of RXRalpha LBD in complex with LG 100754 and a coactivator peptide	0.122	230	174	179	408	1	199	8.003E-01	29
LOKIASV2_2730_ESMFold_hypothetical_protein	6d6u-assembly1.cif.gz_E	LOKIASV2_2730_ESMFold_hypothetical_protein	6d6u-assembly1.cif.gz_E Human GABA-A receptor alpha1-beta2-gamma2 subtype in complex with GABA and flumazenil, conformation A	0.115	118	99	319	436	204	316	6.135E+00	29
LOKIASV2_2730_ESMFold_hypothetical_protein	7y6i-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7y6i-assembly1.cif.gz_B Cryo-EM structure of human sodium-chloride cotransporter	0.100	432	338	19	395	37	468	4.758E-01	29
LOKIASV2_2730_ESMFold_hypothetical_protein	7z7v-assembly1.cif.gz_N	LOKIASV2_2730_ESMFold_hypothetical_protein	7z7v-assembly1.cif.gz_N Complex I from E. coli, LMNG-purified, under Turnover at pH 6, Open-ready state	0.119	469	374	19	444	8	476	5.418E-01	29
LOKIASV2_2730_ESMFold_hypothetical_protein	3usp-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3usp-assembly1.cif.gz_A Crystal structure of LeuT in heptyl-beta-D-Selenoglucoside	0.134	426	352	21	428	39	464	2.594E-01	29
LOKIASV2_2730_ESMFold_hypothetical_protein	7a78-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	7a78-assembly1.cif.gz_A-2 Crystal structure of RXR beta LBD in complexes with palmitic acid and GRIP-1 peptide	0.122	237	183	179	415	1	209	8.727E-01	28
LOKIASV2_2730_ESMFold_hypothetical_protein	5hjp-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5hjp-assembly1.cif.gz_A Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	0.125	237	185	185	421	3	214	8.357E-01	28
LOKIASV2_2730_ESMFold_hypothetical_protein	7p7e-assembly1.cif.gz_L	LOKIASV2_2730_ESMFold_hypothetical_protein	7p7e-assembly1.cif.gz_L Complex I from E. coli, DDM/LMNG-purified, Apo, Resting state	0.103	388	334	66	438	140	527	9.114E-01	28
LOKIASV2_2730_ESMFold_hypothetical_protein	6khj-assembly1.cif.gz_F	LOKIASV2_2730_ESMFold_hypothetical_protein	6khj-assembly1.cif.gz_F Supercomplex for electron transfer	0.101	439	338	66	442	143	581	9.518E-01	28
LOKIASV2_2730_ESMFold_hypothetical_protein	5gpj-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5gpj-assembly1.cif.gz_B Crystal Structure of Proton-Pumping Pyrophosphatase	0.122	336	283	66	401	20	342	1.746E+00	28
LOKIASV2_2730_ESMFold_hypothetical_protein	5mj5-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	5mj5-assembly1.cif.gz_A-2 Crystal structure of the Retinoid X Receptor alpha in complex with synthetichonokiol derivative 3 and a fragment of the TIF2 co-activator.	0.101	242	178	167	408	4	202	8.357E-01	27
LOKIASV2_2730_ESMFold_hypothetical_protein	3wak-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3wak-assembly1.cif.gz_A Crystal structure of the Archaeoglobus fulgidus oligosaccharyltransferase (O29867_ARCFU) in the apo form	0.108	496	385	15	447	3	498	2.168E+00	27
LOKIASV2_2730_ESMFold_hypothetical_protein	3kwy-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	3kwy-assembly1.cif.gz_A-2 Crystal structure of RXRalpha ligand binding domain in complex with triphenyltin and a coactivator fragment	0.126	237	180	179	415	1	207	1.346E+00	26
LOKIASV2_2730_ESMFold_hypothetical_protein	5mku-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	5mku-assembly1.cif.gz_A-2 Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 4 and a fragment of the TIF2 co-activator.	0.129	226	171	185	410	4	200	1.346E+00	25
LOKIASV2_2730_ESMFold_hypothetical_protein	5mk4-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5mk4-assembly1.cif.gz_A Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 7 and a fragment of the TIF2 co-activator.	0.116	244	178	167	410	4	205	8.727E-01	25
LOKIASV2_2730_ESMFold_hypothetical_protein	1mv9-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1mv9-assembly1.cif.gz_A Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide	0.126	238	179	185	422	4	209	1.406E+00	25
LOKIASV2_2730_ESMFold_hypothetical_protein	7unh-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7unh-assembly1.cif.gz_A De novo designed chlorophyll dimer protein in apo state, SP2	0.076	316	219	84	399	3	240	4.730E+00	25
LOKIASV2_2730_ESMFold_hypothetical_protein	7djc-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7djc-assembly1.cif.gz_A Crystal structure of the G26C/Q250A mutant of LeuT	0.141	410	350	19	426	45	454	6.729E-01	25
LOKIASV2_2730_ESMFold_hypothetical_protein	3gwv-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3gwv-assembly1.cif.gz_A Leucine transporter LeuT in complex with R-fluoxetine	0.134	424	351	21	426	39	462	5.658E-01	25
LOKIASV2_2730_ESMFold_hypothetical_protein	8bqs-assembly1.cif.gz_AC	LOKIASV2_2730_ESMFold_hypothetical_protein	8bqs-assembly1.cif.gz_AC Cryo-EM structure of the I-II-III2-IV2 respiratory supercomplex from Tetrahymena thermophila	0.112	491	364	13	423	2	492	1.672E+00	25
LOKIASV2_2730_ESMFold_hypothetical_protein	5z12-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5z12-assembly2.cif.gz_C A structure of FXR/RXR	0.100	156	135	253	408	44	194	1.601E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_B Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with BMS649 and a coactivator fragment	0.139	230	170	179	408	1	198	1.823E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	6lb5-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6lb5-assembly1.cif.gz_A Crystal structure of dimeric RXR-LBD complexed with full agonist NEt-3IB and TIF2 co-activator	0.123	230	175	179	408	1	200	1.904E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	5i4v-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5i4v-assembly1.cif.gz_B Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists	0.121	237	184	185	421	5	214	1.746E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	5mk4-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5mk4-assembly1.cif.gz_C Crystal structure of the Retinoid X Receptor alpha in complex with synthetic honokiol derivative 7 and a fragment of the TIF2 co-activator.	0.119	244	178	167	410	4	206	1.132E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	6si5-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	6si5-assembly1.cif.gz_A-2 T. cruzi FPPS in complex with 1-methyl-5-(4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5-carbonyl)pyridin-2(1H)-one	0.097	352	277	114	421	1	352	1.823E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	3gia-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3gia-assembly1.cif.gz_A Crystal Structure of ApcT Transporter	0.131	396	331	21	402	27	422	1.289E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	7z7s-assembly1.cif.gz_N	LOKIASV2_2730_ESMFold_hypothetical_protein	7z7s-assembly1.cif.gz_N Complex I from E. coli, LMNG-purified, under Turnover at pH 6, Closed state	0.124	446	355	19	424	8	453	1.132E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	8e73-assembly1.cif.gz_5M	LOKIASV2_2730_ESMFold_hypothetical_protein	8e73-assembly1.cif.gz_5M Vigna radiata supercomplex I+III2 (full bridge)	0.120	360	304	66	411	133	492	1.601E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	7e9s-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7e9s-assembly1.cif.gz_A Archaeal oligosaccharyltransferase AglB from Archaeoglobus fulgidus in complex with an inhibitory peptide and a dolichol-phosphate	0.115	497	383	14	447	1	497	3.344E+00	24
LOKIASV2_2730_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_A Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with BMS649 and a coactivator fragment	0.112	249	181	167	415	4	208	1.468E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	6jnr-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6jnr-assembly1.cif.gz_A RXRa structure complexed with CU-6PMN and SRC1 peptide.	0.110	237	186	179	415	1	210	2.168E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	5ji0-assembly2.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5ji0-assembly2.cif.gz_A PPARgamma-RXRalpha(S427F) heterodimer in complex with SRC-1, rosiglitazone, and 9-cis-retanoic acid	0.115	161	139	251	408	50	210	2.365E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	5kyj-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5kyj-assembly1.cif.gz_B Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.095	233	194	189	421	2	216	1.346E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	1m7w-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	1m7w-assembly1.cif.gz_B HNF4a ligand binding domain with bound fatty acid	0.102	247	190	191	437	3	215	2.693E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	7bk4-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7bk4-assembly1.cif.gz_A Crystal structure of RXRalpha ligand binding domain in complex with a fragment of the TIF2 coactivator	0.100	242	186	167	408	7	214	1.746E+00	23
LOKIASV2_2730_ESMFold_hypothetical_protein	4ozr-assembly1.cif.gz_U	LOKIASV2_2730_ESMFold_hypothetical_protein	4ozr-assembly1.cif.gz_U Crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (methylene lactam crystal)	0.137	141	117	267	403	45	185	2.812E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	3r2a-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	3r2a-assembly1.cif.gz_C Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist rhein	0.126	156	135	255	410	44	198	4.338E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	6a5y-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6a5y-assembly1.cif.gz_D Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1	0.129	163	138	253	415	50	209	2.469E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	7a79-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7a79-assembly1.cif.gz_B Crystal structure of RXR gamma LBD in complexes with palmitic acid and GRIP-1 peptide	0.097	249	188	167	415	6	214	1.406E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	5kya-assembly2.cif.gz_F	LOKIASV2_2730_ESMFold_hypothetical_protein	5kya-assembly2.cif.gz_F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.120	238	186	185	422	5	216	2.469E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	3a9e-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3a9e-assembly1.cif.gz_A Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer ligand binding domains	0.100	165	143	253	417	58	217	2.469E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	7a77-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	7a77-assembly1.cif.gz_A-2 Crystal structure of RXR alpha LBD in complexes with palmitic acid and GRIP-1 peptide	0.114	249	190	167	415	8	222	1.746E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_B Human LXR-beta in complex with a ligand	0.080	250	202	162	411	6	226	1.468E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_A HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	0.128	190	142	255	444	67	230	4.940E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	7b9s-assembly1.cif.gz_3	LOKIASV2_2730_ESMFold_hypothetical_protein	7b9s-assembly1.cif.gz_3 Structure of the mycobacterial ESX-5 Type VII Secretion System hexameric pore complex	0.127	377	313	65	441	125	484	2.812E+00	22
LOKIASV2_2730_ESMFold_hypothetical_protein	3p5n-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	3p5n-assembly1.cif.gz_B Structure and mechanism of the S component of a bacterial ECF transporter	0.131	169	140	264	432	5	166	6.135E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_C Complex Structure of LXR with an agonist	0.082	235	162	162	396	4	181	1.988E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_B RXRa structure complexed with CU-6PMN	0.106	182	136	256	408	12	193	2.812E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	1uhl-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1uhl-assembly1.cif.gz_A Crystal structure of the LXRalfa-RXRbeta LBD heterodimer	0.132	152	130	257	408	53	203	3.203E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	7aos-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7aos-assembly1.cif.gz_A crystal structure of the RARalpha/RXRalpha ligand binding domain heterodimer in complex with a fragment of SRC1 coactivator	0.093	241	182	167	407	8	209	2.076E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	5hjp-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5hjp-assembly2.cif.gz_C Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	0.133	237	184	185	421	3	215	3.203E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	6lb4-assembly1.cif.gz_A-2	LOKIASV2_2730_ESMFold_hypothetical_protein	6lb4-assembly1.cif.gz_A-2 Crystal structure of dimeric RXR-LBD complexed with NEt-3ME and TIF2 co-activator	0.097	249	189	167	415	6	215	2.365E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_D CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	0.105	242	182	162	403	5	208	1.406E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly1.cif.gz_B CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	0.088	249	201	162	410	5	225	1.406E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	1yp0-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1yp0-assembly1.cif.gz_A Structure of the steroidogenic factor-1 ligand binding domain bound to phospholipid and a SHP peptide motif	0.131	194	133	253	446	75	228	5.159E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	8huk-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	8huk-assembly2.cif.gz_C X-ray structure of human PPAR alpha ligand binding domain-lanifibranor-SRC1 coactivator peptide co-crystals obtained by soaking	0.100	159	140	259	415	97	255	3.493E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	1i7g-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1i7g-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242	0.118	166	142	243	404	77	242	3.344E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	4iqr-assembly2.cif.gz_F	LOKIASV2_2730_ESMFold_hypothetical_protein	4iqr-assembly2.cif.gz_F Multi-Domain Organization of the HNF4alpha Nuclear Receptor Complex on DNA	0.151	159	134	258	416	153	311	4.338E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	7wg5-assembly1.cif.gz_F	LOKIASV2_2730_ESMFold_hypothetical_protein	7wg5-assembly1.cif.gz_F Cyclic electron transport supercomplex NDH-PSI from Arabidopsis	0.090	483	340	66	440	144	626	4.154E+00	21
LOKIASV2_2730_ESMFold_hypothetical_protein	2gl8-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	2gl8-assembly1.cif.gz_B Human Retinoic acid receptor RXR-gamma ligand-binding domain	0.084	218	167	192	409	4	186	4.338E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	1z5x-assembly1.cif.gz_U	LOKIASV2_2730_ESMFold_hypothetical_protein	1z5x-assembly1.cif.gz_U hemipteran ecdysone receptor ligand-binding domain complexed with ponasterone A	0.132	170	139	253	422	31	191	7.296E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_A Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003	0.101	165	143	253	417	34	193	2.365E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	6a5z-assembly2.cif.gz_L	LOKIASV2_2730_ESMFold_hypothetical_protein	6a5z-assembly2.cif.gz_L Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1	0.120	224	172	185	408	3	198	4.730E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	6a60-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6a60-assembly1.cif.gz_D Crystal structure of human FXR/RXR-LBD heterodimer bound to GW4064 and 9cRA and SRC1	0.129	231	177	185	415	5	208	4.730E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	1rdt-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1rdt-assembly1.cif.gz_A Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer	0.124	231	180	185	415	5	210	4.154E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_B Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.113	238	186	185	422	5	215	2.693E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	3ips-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3ips-assembly1.cif.gz_A X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha	0.086	248	194	163	410	6	218	2.076E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	6s4n-assembly4.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6s4n-assembly4.cif.gz_C LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.120	248	186	162	409	5	216	2.469E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	4j5w-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	4j5w-assembly1.cif.gz_C Crystal Structure of the apo-PXR/RXRalpha LBD Heterotetramer Complex	0.112	245	198	178	422	2	225	3.647E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	1pzl-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1pzl-assembly1.cif.gz_A Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide	0.128	257	191	162	418	6	225	3.203E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	7f02-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7f02-assembly1.cif.gz_C Cytochrome c-type biogenesis protein CcmABCD from E. coli	0.134	125	103	324	448	68	187	9.062E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	6k9m-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6k9m-assembly2.cif.gz_B Human LXR-beta in complex with an agonist	0.087	250	200	162	411	6	225	1.823E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	3fei-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3fei-assembly1.cif.gz_A Design and biological evaluation of novel, balanced dual PPARa/g agonists	0.127	151	131	259	409	84	234	4.940E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	7bpz-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7bpz-assembly2.cif.gz_C X-ray structure of human PPARalpha ligand binding domain-bezafibrate-SRC1 coactivator peptide co-crystals obtained by soaking	0.125	168	145	243	409	80	247	3.067E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	3ay5-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3ay5-assembly1.cif.gz_A Crystal structure of HHM (human homologue of murine maternal Id-like molecule)	0.106	294	218	163	407	5	298	3.978E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	7bp3-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7bp3-assembly1.cif.gz_B Cryo-EM structure of the human MCT2	0.117	391	318	88	448	3	393	3.809E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	7oy2-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7oy2-assembly1.cif.gz_C High resolution structure of cytochrome bd-II oxidase from E. coli	0.124	334	212	69	402	6	248	2.264E+00	20
LOKIASV2_2730_ESMFold_hypothetical_protein	2gl8-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	2gl8-assembly1.cif.gz_A Human Retinoic acid receptor RXR-gamma ligand-binding domain	0.093	140	125	257	396	41	179	5.159E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_A Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	0.143	161	130	256	408	33	193	2.168E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_C RXRa structure complexed with CU-6PMN	0.089	177	141	253	429	44	199	3.809E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	3fc6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3fc6-assembly1.cif.gz_A hRXRalpha & mLXRalpha with an indole Pharmacophore, SB786875	0.106	227	167	185	411	8	195	4.730E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	7nke-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7nke-assembly1.cif.gz_C Crystal structure of human RXRalpha ligand binding domain in complex with 2,4-di-tert-butylphenol and a coactivator fragment	0.108	161	140	251	408	42	202	3.344E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_B Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003	0.112	178	141	253	430	51	210	6.135E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	1xdk-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1xdk-assembly1.cif.gz_A Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator	0.085	249	189	167	415	7	214	4.530E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	5kyj-assembly2.cif.gz_F	LOKIASV2_2730_ESMFold_hypothetical_protein	5kyj-assembly2.cif.gz_F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.115	234	180	182	415	2	205	3.493E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	3uvv-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	3uvv-assembly1.cif.gz_B Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3',5 triiodo-L-thyronine and 9-cis retinoic acid	0.094	249	189	167	415	6	215	4.154E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	5gtr-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5gtr-assembly1.cif.gz_A estrogen receptor alpha in complex with a stabilized peptide antagonist 6	0.109	280	193	166	445	8	225	3.978E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	0.114	203	175	245	447	34	232	6.135E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	8fbi-assembly1.cif.gz_A-3	LOKIASV2_2730_ESMFold_hypothetical_protein	8fbi-assembly1.cif.gz_A-3 Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains	0.085	358	245	66	423	3	271	9.463E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	1sj8-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1sj8-assembly1.cif.gz_A Solution Structure of the R1R2 Domains of Talin	0.073	310	263	115	424	6	290	3.809E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	3hd6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3hd6-assembly1.cif.gz_A Crystal Structure of the Human Rhesus Glycoprotein RhCG	0.127	408	321	14	421	8	376	4.530E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	6hum-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6hum-assembly1.cif.gz_D Structure of the photosynthetic complex I from Thermosynechococcus elongatus	0.079	453	367	25	424	2	454	3.493E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	7z0s-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7z0s-assembly1.cif.gz_C Structure of the Escherichia coli formate hydrogenlyase complex (anaerobic preparation, without formate dehydrogenase H)	0.105	492	382	21	448	5	496	5.159E+00	19
LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_D RXRa structure complexed with CU-6PMN	0.109	172	135	255	426	48	199	6.987E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_C Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	0.125	233	178	185	417	2	205	5.875E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5tbp-assembly2.cif.gz_C Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003	0.122	163	136	253	408	51	213	4.154E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7a79-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7a79-assembly1.cif.gz_A Crystal structure of RXR gamma LBD in complexes with palmitic acid and GRIP-1 peptide	0.104	242	177	167	408	6	203	4.154E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	2zy0-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	2zy0-assembly1.cif.gz_C Crystal structure of the human RXR alpha ligand binding domain bound to a synthetic agonist compound and a coactivator peptide	0.124	231	176	178	408	2	203	6.407E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	1dkf-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	1dkf-assembly1.cif.gz_A CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS	0.127	247	186	176	422	2	215	5.875E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	5z12-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5z12-assembly1.cif.gz_B A structure of FXR/RXR	0.095	249	189	167	415	5	214	3.493E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	5yxl-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5yxl-assembly1.cif.gz_A A ligand M binding to FXR	0.086	277	182	161	437	2	201	6.691E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	5avi-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5avi-assembly1.cif.gz_C Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4	0.079	252	201	164	415	5	223	5.159E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	6hn6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6hn6-assembly1.cif.gz_A A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor RXR-ALPHA	0.115	242	200	167	408	8	234	3.067E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7k2t-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7k2t-assembly1.cif.gz_B Mg2+/ATP-bound structure of the full-length WzmWzt O antigen ABC transporter in lipid nanodiscs	0.114	342	213	99	440	4	244	8.309E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	8b8x-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	8b8x-assembly2.cif.gz_B Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist	0.080	154	137	253	406	103	252	4.730E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	6l96-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6l96-assembly1.cif.gz_B Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide	0.120	146	127	255	400	89	233	5.626E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	8b8z-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8b8z-assembly1.cif.gz_A Crystal structure of mutant PPARG (C313A) and NCOR2 with an inverse agonist (compound 7e)	0.086	155	140	255	409	106	259	4.940E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	3gz9-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3gz9-assembly1.cif.gz_A Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Full Agonist	0.090	177	155	245	415	84	260	4.940E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7mxz-assembly1.cif.gz_BBB	LOKIASV2_2730_ESMFold_hypothetical_protein	7mxz-assembly1.cif.gz_BBB Sy-CrtE apo structure	0.075	286	261	110	395	1	283	6.407E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7aik-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7aik-assembly1.cif.gz_A Ribonucleotide Reductase R2 protein from Aquifex aeolicus	0.110	272	225	162	415	47	318	4.940E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	5qpj-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5qpj-assembly1.cif.gz_A PanDDA analysis group deposition -- Crystal Structure of T. cruzi FPPS in complex with FMOPL000465a	0.100	354	281	113	425	1	354	4.154E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	8ont-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8ont-assembly1.cif.gz_A Structure of Setaria italica NRAT in complex with a nanobody	0.115	426	327	20	445	34	404	4.940E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7mhz-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7mhz-assembly1.cif.gz_A Human Hedgehog acyltransferase (HHAT) in complex with a palmitoylated Hedgehog peptide product and a Fab antibody fragment	0.096	489	376	13	429	2	490	2.264E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	1is2-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	1is2-assembly1.cif.gz_B Crystal Structure of Peroxisomal Acyl-CoA Oxidase-II from Rat Liver	0.103	393	317	19	411	271	624	3.978E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	7nvh-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7nvh-assembly1.cif.gz_A Cryo-EM structure of the mycolic acid transporter MmpL3 from M. tuberculosis	0.092	525	320	68	420	167	691	3.067E+00	18
LOKIASV2_2730_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_C Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	0.117	172	144	245	408	32	203	3.344E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	6lb5-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	6lb5-assembly1.cif.gz_C Crystal structure of dimeric RXR-LBD complexed with full agonist NEt-3IB and TIF2 co-activator	0.109	160	141	257	415	59	218	4.730E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	1xvp-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	1xvp-assembly2.cif.gz_C crystal structure of CAR/RXR heterodimer bound with SRC1 peptide, fatty acid and CITCO	0.114	242	190	167	408	6	220	6.135E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	6l89-assembly1.cif.gz_B-2	LOKIASV2_2730_ESMFold_hypothetical_protein	6l89-assembly1.cif.gz_B-2 Human PPARgamma ligand binding domain complexed with Butyrolactone 1	0.084	178	145	253	411	65	242	5.875E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	8wfe-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8wfe-assembly1.cif.gz_A The Crystal Structure of PPARg from Biortus.	0.099	161	144	255	415	93	253	5.387E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	3cwd-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	3cwd-assembly2.cif.gz_B Molecular recognition of nitro-fatty acids by PPAR gamma	0.081	151	138	259	409	99	249	6.407E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	3et1-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3et1-assembly1.cif.gz_A Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid	0.075	255	228	161	415	3	249	5.387E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	6lxa-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6lxa-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-eicosapentaenoic acid (EPA) co-crystals obtained by delipidation and cross-seeding	0.122	152	133	258	409	106	257	8.677E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	4jxy-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	4jxy-assembly1.cif.gz_A CRYSTAL STRUCTURE OF POLYPRENYL SYNTHASE PATL_3739 (TARGET EFI-509195) FROM Pseudoalteromonas atlantica	0.103	310	268	110	419	3	302	3.647E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly1.cif.gz_C Crystal structure of the nucleoporin pair Nup85-Seh1, space group P21212	0.110	412	335	26	402	67	478	4.940E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly2.cif.gz_G	LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly2.cif.gz_G Crystal structure of the nucleoporin pair Nup85-Seh1, space group P21212	0.104	415	338	27	404	68	482	2.264E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	8pm6-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8pm6-assembly1.cif.gz_A Human bile salt export pump (BSEP) in complex with inhibitor GBM in nanodiscs	0.090	421	367	2	422	180	583	3.978E+00	17
LOKIASV2_2730_ESMFold_hypothetical_protein	3r5m-assembly1.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	3r5m-assembly1.cif.gz_C Crystal structure of RXRalphaLBD complexed with the agonist magnolol	0.109	242	175	167	408	5	201	6.135E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	4qe8-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	4qe8-assembly2.cif.gz_B FXR with DM175 and NCoA-2 peptide	0.129	283	187	161	443	8	223	8.309E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	3bej-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3bej-assembly1.cif.gz_A Structure of human FXR in complex with MFA-1 and co-activator peptide	0.122	284	183	153	436	1	209	7.957E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	1mzn-assembly2.cif.gz_E	LOKIASV2_2730_ESMFold_hypothetical_protein	1mzn-assembly2.cif.gz_E CRYSTAL STRUCTURE at 1.9 ANGSTROEMS RESOLUTION OF THE HOMODIMER OF HUMAN RXR ALPHA LIGAND BINDING DOMAIN BOUND TO THE SYNTHETIC AGONIST COMPOUND BMS 649 AND A COACTIVATOR PEPTIDE	0.105	242	184	167	408	6	212	6.135E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.117	203	154	243	445	49	223	8.309E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_D Complex Structure of LXR with an agonist	0.091	249	204	162	410	4	228	7.296E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	3l0e-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3l0e-assembly1.cif.gz_A X-ray crystal structure of a Potent Liver X Receptor Modulator	0.087	303	212	115	417	9	241	6.135E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	8b93-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8b93-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 15b)	0.085	155	135	253	407	100	248	6.987E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	3kmg-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	3kmg-assembly1.cif.gz_A The X-ray Crystal Structure of PPAR-gamma in Complex with an Indole Derivative Modulator, GSK538, and an SRC-1 Peptide	0.081	158	136	253	410	97	245	9.062E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	2zvt-assembly2.cif.gz_B-2	LOKIASV2_2730_ESMFold_hypothetical_protein	2zvt-assembly2.cif.gz_B-2 Cys285Ser mutant PPARgamma ligand-binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2	0.088	180	142	251	407	78	257	5.626E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	7e5g-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7e5g-assembly1.cif.gz_A HUMAN PPAR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH YN4pai OBTAINED BY SOAKING	0.122	152	133	258	409	102	253	9.463E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	5jdm-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5jdm-assembly1.cif.gz_A Structural mechanisms of extracellular ion exchange and induced binding-site occlusion in the sodium-calcium exchanger NCX_Mj soaked with 2.5 mM Na+ and 0.1mM Sr2+	0.122	415	247	16	430	10	291	4.940E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	5c65-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5c65-assembly1.cif.gz_A Structure of the human glucose transporter GLUT3 / SLC2A3	0.121	310	171	87	396	6	200	4.730E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	7dsv-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	7dsv-assembly1.cif.gz_B Structure of a human NHE1-CHP1 complex under pH 6.5	0.138	358	295	81	438	10	352	6.987E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	7o3e-assembly1.cif.gz_a	LOKIASV2_2730_ESMFold_hypothetical_protein	7o3e-assembly1.cif.gz_a Murine supercomplex CIII2CIV in the intermediate locked conformation	0.104	346	306	65	410	146	488	7.619E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	8jd9-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8jd9-assembly1.cif.gz_A Cyro-EM structure of the Na+/H+ antipoter SOS1 from Arabidopsis thaliana,class1	0.129	417	339	21	410	16	432	4.154E+00	16
LOKIASV2_2730_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_B Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	0.126	157	134	255	408	42	198	6.987E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	5yxl-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5yxl-assembly2.cif.gz_C A ligand M binding to FXR	0.108	268	171	163	430	4	196	7.957E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	5q0t-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5q0t-assembly1.cif.gz_A Ligand binding to FARNESOID-X-RECEPTOR	0.111	262	172	163	424	7	200	6.135E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly1.cif.gz_A CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	0.097	255	200	162	416	5	226	6.135E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	1dkf-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	1dkf-assembly1.cif.gz_B CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS	0.105	212	164	197	408	40	223	7.619E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	2qgw-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	2qgw-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed with a Chloro-Indazole Compound	0.106	210	157	238	447	55	231	8.309E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	5w9d-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5w9d-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen	0.117	203	159	243	445	48	228	9.062E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	4ema-assembly3.cif.gz_B-2	LOKIASV2_2730_ESMFold_hypothetical_protein	4ema-assembly3.cif.gz_B-2 Human peroxisome proliferator-activated receptor gamma in complex with rosiglitazone	0.087	159	131	253	411	89	233	8.677E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	4r6s-assembly2.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	4r6s-assembly2.cif.gz_A Crystal structure of PPARgammma in complex with SR1663	0.076	249	228	161	409	7	254	7.619E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	5x87-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5x87-assembly1.cif.gz_B Crystal structure of a bacterial Bestrophin homolog from Klebsiella pneumoniae with a mutation L177T	0.098	337	231	85	421	2	258	9.882E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	6l7p-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6l7p-assembly1.cif.gz_A cryo-EM structure of cyanobacteria NDH-1LdelV complex	0.130	390	303	6	395	9	357	7.619E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	6wh4-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6wh4-assembly1.cif.gz_A Crystal structure of HTR2A with inverse agonist	0.106	362	271	81	442	3	306	8.309E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	8fth-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8fth-assembly1.cif.gz_A Chaetomium thermophilum SETX - NPPC internal deletion	0.108	387	318	65	422	161	547	7.957E+00	15
LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_D Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	0.137	159	131	256	408	29	187	6.691E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	6s4n-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	6s4n-assembly1.cif.gz_D LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.121	174	151	238	410	56	229	9.062E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	0.084	240	192	157	396	4	214	9.062E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	6s4t-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6s4t-assembly1.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.071	249	211	162	410	5	232	9.463E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	3r8a-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	3r8a-assembly2.cif.gz_B X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity	0.088	249	208	161	409	4	232	9.882E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	3kdt-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	3kdt-assembly1.cif.gz_B Crystal structure of peroxisome proliferator-activatedeceptor alpha (PPARalpha) complex with N-3-((2-(4-Chlorophenyl)-5-methyl-1,3-oxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine	0.089	254	228	159	409	7	260	7.619E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	2dh4-assembly1.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	2dh4-assembly1.cif.gz_B Geranylgeranyl pyrophosphate synthase	0.090	290	258	154	443	43	326	9.882E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	6bd4-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6bd4-assembly1.cif.gz_A Crystal structure of human apo-Frizzled4 receptor	0.123	263	178	160	422	33	236	9.463E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	6gw5-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	6gw5-assembly1.cif.gz_A X-ray structure of the Helicobacter pylori SabA adhesin domain	0.085	350	304	115	447	3	352	6.987E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	4usz-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	4usz-assembly1.cif.gz_A Crystal structure of the first bacterial vanadium dependant iodoperoxidase	0.077	287	204	160	381	9	295	7.957E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	7tc8-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	7tc8-assembly1.cif.gz_D Cryo-EM structure of methane monooxygenase hydroxylase (by graphene)	0.106	253	182	142	394	36	240	7.296E+00	14
LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_C	LOKIASV2_2730_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_C CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	0.096	236	186	161	396	4	210	9.062E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	5dhh-assembly3.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	5dhh-assembly3.cif.gz_A The crystal structure of nociceptin/orphanin FQ peptide receptor (NOP) in complex with SB-612111 (PSI Community Target)	0.112	330	237	67	396	4	271	9.882E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	8jtc-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	8jtc-assembly1.cif.gz_A Human VMAT2 complex with reserpine	0.115	388	300	69	408	4	391	8.677E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	5c65-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	5c65-assembly2.cif.gz_B Structure of the human glucose transporter GLUT3 / SLC2A3	0.121	310	169	87	396	5	197	8.309E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly1.cif.gz_D	LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly1.cif.gz_D Crystal structure of the nucleoporin pair Nup85-Seh1, space group P21212	0.110	413	329	27	397	63	475	7.296E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly3.cif.gz_L	LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly3.cif.gz_L Crystal structure of the nucleoporin pair Nup85-Seh1, space group P21212	0.108	406	317	26	381	68	473	5.626E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly3.cif.gz_K	LOKIASV2_2730_ESMFold_hypothetical_protein	3f3p-assembly3.cif.gz_K Crystal structure of the nucleoporin pair Nup85-Seh1, space group P21212	0.106	416	331	27	397	68	483	6.407E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	7y1l-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7y1l-assembly1.cif.gz_A Structure of SUR2B in complex with Mg-ATP and repaglinide in the inward-facing conformation	0.106	411	315	15	425	14	366	6.135E+00	13
LOKIASV2_2730_ESMFold_hypothetical_protein	6gw5-assembly2.cif.gz_B	LOKIASV2_2730_ESMFold_hypothetical_protein	6gw5-assembly2.cif.gz_B X-ray structure of the Helicobacter pylori SabA adhesin domain	0.089	335	302	115	447	14	348	7.957E+00	12
LOKIASV2_2730_ESMFold_hypothetical_protein	7niw-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7niw-assembly1.cif.gz_A Nanodisc reconstituted human ABCB4 in complex with 4B1-Fab (posaconazole-bound, inward-open conformation)	0.098	397	288	13	409	6	325	9.882E+00	12
LOKIASV2_2730_ESMFold_hypothetical_protein	7zk4-assembly1.cif.gz_A	LOKIASV2_2730_ESMFold_hypothetical_protein	7zk4-assembly1.cif.gz_A The ABCB1 L335C mutant (mABCB1) in the outward facing state	0.106	401	304	8	408	6	346	6.987E+00	12
